Varicella seroprevalence and vaccine uptake in preschool children

Gwendolyn L Gilbert,* Heather F Gidding,^† Josephine Backhouse,^‡ Peter B McIntyre^§

1 Centre for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, PO Box 533, Wentworthville, NSW 2145.
3 National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead, NSW.

Correspondence: Lyng@icpmr.wsahs.nsw.gov.au

1. Scuffham PA, Lowin AV, Burgess MA. The cost-effectiveness of varicella vaccine programs for Australia. Vaccine 2000; 18: 407-415.
2. Burgess MA, McIntyre PB. Vaccines: the new Australian best-practice schedule [editorial]. Med J Aust 2004; 180: 494-496. <MJA full text>
3. Brisson M, Edmonds WJ, Gay NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 2003: 70 Suppl 1: S31-S37.
4. Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect 2003; 131: 1085-1089.
5. Britt H, Miller GC, Knox S, et al. General practice activity in Australia 2002–03. AIHW Cat. No. GEP 14 (General Practice Series No. 14). Canberra: Australian Institute of Health and Welfare; 2003.

Online responses are no longer available. Please refer to our instructions for authors page for more information.